Posted by Michael Wonder on 31 Aug 2022
Kidney disease drug dapagliflozin added to Pharmaceutical Benefits Scheme
31 August 2022 - Lachlan Ross describes his more than a decade-long battle with kidney failure as "very long, and very hard."
The 54 year old from the NT remote community of Lajamanu has been lucky enough to receive a kidney transplant, meaning he no longer has to receive thrice-weekly dialysis treatments.
